EMIS Group (EMIS) Half-year results presentation 2021

Emis’s CEO, Andy Thornburn and CFO, Peter Southby present interim results for the six months ended 30 June 2021. Revenue and adjusted operating profit were ahead of both H1 20 and 19. Recurring revenue represents 79%. The dividend has grown to 10%. EMIS Enterprise was boosted by the use of the Outcomes4Health solution to support the CV19 roll-out in England. EMIS-X development continues and is building strong foundations for future growth. The outlook is in line with expectations for the full year. Andy Thorburn, CEO 00:17 Introduction Peter Southby, CFO 01:00 Financial highlights 02:43 Income statement 04:10 Segmental analysis 05:13 Revenue analysis 06:26 Cash flow 07:43 Balance sheet 08:21 Guidance and trends Andy Thorburn, CEO 10:00 Operational review 11:17 H1 positive progress 14:50 Healthcare market evolution 18:00 Accelerating growth over the coming years 28:49 Market positioning and capabilities 29:55 Outlook EMIS Group plc provides healthcare software, information technology and related services in the United Kingdom. The Company’s segments include Primary & Community Care and Community Pharmacy. The Company serves various healthcare markets under the EMIS Health brand. The Primary & Community Care division provides clinical information technology (IT) systems for general practitioners (GPs) and commissioners. The Community Pharmacy division is an integrated community pharmacy dispensary and retail system. EMIS Health provides clinical software to customers across the healthcare sector. Its brand EMIS Care specializes in the delivery of diabetic retinopathy eye screening.